If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRights &iss. Regulatory News (RIII)

Share Price Information for Rights &iss. (RIII)

Share Price is delayed by 15 minutes
Get Live Data
2,240.00    0.00 (0.00%)
Bid:
2,180.00
Ask:
2,300.00
Spread: 120.00 (5.505%)
Market Cap: £105.44m
RIII Live PriceLast checked at - London Stock Exchange

Intraday Rights &iss. Share Chart

Annual Overview from QuotedData

6 Nov 2025 15:56

RNS Number : 5534G
Rights and Issues Inv. Trust PLC
06 November 2025
 

Rights and Issues Investment Trust - Annual overview from QuotedData

6 November 2025

Looking oversold

Rights and Issues Investment Trust (RIII) is battling a number of headwinds. UK small caps face a lacklustre UK economy, a looming budget that is creating market uncertainty, and seemingly indifferent domestic and international investors. To this we can add a large shareholder who appears to be actively frustrating efforts by RIII's board to improve the lot of investors. This has led to a widening of RIII's discount, which makes it amongst the worst-performing of all UK small-cap trusts over the past 12 months.

The upshot of this is that RIII looks cheap relative to peers and its history, and so does its portfolio. The upside, if things turn around, could be dramatic.

Full Research:

https://quoteddata.com/research/rights-and-issues-investment-trust-looking-oversold-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note Rights and Issues Investment Trust Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUNVVRVUUARAA
Date   Source Headline
26th Mar 20263:35 pmRNSNet Asset Value(s)
25th Mar 20261:39 pmRNSNet Asset Value(s)
24th Mar 202612:45 pmRNSNet Asset Value(s)
23rd Mar 20261:44 pmRNSNet Asset Value(s)
20th Mar 20262:02 pmRNSNet Asset Value(s)
19th Mar 20261:13 pmRNSNet Asset Value(s)
18th Mar 20262:57 pmRNSNet Asset Value(s)
17th Mar 20261:16 pmRNSNet Asset Value(s)
11th Mar 20267:00 amRNS-RKepler Trust Intelligence: New Research
11th Mar 20267:00 amRNS-RKepler Trust Intelligence: New Research
10th Mar 20263:07 pmRNSNet Asset Value(s)
9th Mar 20261:54 pmRNSNet Asset Value(s)
6th Mar 20261:10 pmRNSNet Asset Value(s)
5th Mar 20261:01 pmRNSNet Asset Value(s)
4th Mar 20262:02 pmRNSNet Asset Value(s)
3rd Mar 20262:17 pmRNSNet Asset Value(s)
2nd Mar 20263:19 pmRNSNet Asset Value(s)
27th Feb 202612:20 pmRNSNet Asset Value(s)
26th Feb 20262:12 pmRNSNet Asset Value(s)
25th Feb 202612:40 pmRNSNet Asset Value(s)
24th Feb 20261:15 pmRNSNet Asset Value(s)
23rd Feb 20262:55 pmRNSNet Asset Value(s)
20th Feb 202612:28 pmRNSNet Asset Value(s)
19th Feb 20262:13 pmRNSNet Asset Value(s)
19th Feb 20267:05 amRNSDividend Declaration
19th Feb 20267:00 amRNSFinal Results
18th Feb 202612:43 pmRNSNet Asset Value(s)
17th Feb 20261:49 pmRNSNet Asset Value(s)
16th Feb 202612:27 pmRNSNet Asset Value(s)
13th Feb 20261:42 pmRNSNet Asset Value(s)
13th Feb 20267:00 amRNSDirectorate change
12th Feb 20262:56 pmRNSNet Asset Value(s)
11th Feb 202612:35 pmRNSNet Asset Value(s)
10th Feb 20262:13 pmRNSNet Asset Value(s)
9th Feb 20265:34 pmRNSNet Asset Value(s)
6th Feb 202610:54 amRNSNet Asset Value(s)
5th Feb 202611:59 amRNSNet Asset Value(s)
4th Feb 202612:55 pmRNSNet Asset Value(s)
3rd Feb 20262:46 pmRNSNet Asset Value(s)
2nd Feb 20261:08 pmRNSNet Asset Value(s)
30th Jan 202612:01 pmRNSNet Asset Value(s)
29th Jan 202611:40 amRNSNet Asset Value(s)
28th Jan 202611:14 amRNSNet Asset Value(s)
27th Jan 202610:18 amRNSNet Asset Value(s)
26th Jan 202611:05 amRNSNet Asset Value(s)
23rd Jan 202612:30 pmRNSNet Asset Value(s)
22nd Jan 202610:45 amRNSNet Asset Value(s)
21st Jan 202610:25 amRNSNet Asset Value(s)
20th Jan 20261:43 pmRNSNet Asset Value(s)
19th Jan 202612:04 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.